Our meta-analysis demonstrates that the presence of high levels of FOXP3+ TILs is associated with prognosis for breast cancer patients and predicts lymph node metastasis, hormone receptor and HER-2 status. The gene discussed is FOXP3; the disease is metastatic malignant neoplasm in the lymph nodes.